Access to Transplant
DPC is committed to ensuring access to all forms of treatment for end-stage renal disease including transplantation. DPC works closely with others within the renal community to advocate for adequate policy solutions that encourage organ donation and protect patients’ health after they receive a transplant.
Related Information
State Legislatures Introduce Bills that Would Positively Impact Dialysis Patients
With the start of the new year, state legislatures throughout the country are beginning their legislative sessions with a flurry of new bills being introduced on a wide-ranging number of topics. While the Covid-19 pandemic [...]
Action Alert – Secure Patient Access to Immunosuppressive Medications
The Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act recently passed in the House and has 24 cosponsors in the Senate. This bill was included in a larger legislative package, and we need [...]
CMS Announces Penalties and Rewards for Promoting Home Dialysis and Transplants
On September 18, the Centers for Medicare & Medicaid Services (CMS) announced it finalized the End-Stage Renal Disease Treatment Choices (ETC) Model. The ETC Model was a cornerstone of President Trump’s Advancing Kidney Health Executive Order [...]
DPC Comments on CMS Proposed ESRD Annual Payment Rule to Increase Dialysis Patient Quality Care
Each year—typically during the summer—the Centers for Medicare and Medicaid Services (CMS) puts out rules for how they are going to pay for dialysis treatment. The rules reflect CMS’ latest policies, and organizations have [...]
DPC’s 2020 Annual Membership Survey is Live!
Elevate the Voice of Patients with Kidney Disease and Their Caregivers Our 2020 Annual Membership Survey is live, and it will remain open until Friday, August 21. We are counting on your participation, as [...]
Action Alert – Secure Patient Access to Immunosuppressive Medications
The Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2019 (H.R. 5534) was recently introduced by Representatives Ron Kind (D-WI) and Michael Burgess (R-TX). This legislation would extend Medicare coverage of immunosuppressant [...]
English
Arabic
Chinese (Simplified)
Dutch
French
German
Italian
Malay
Portuguese
Russian
Spanish